Fabrication of Gelatin Methacrylate (GelMA) Scaffolds with Nano- and Micro-Topographical and Morphological Features.

The design of biomimetic biomaterials for cell culture has become a great tool to study and understand cell behavior, tissue degradation, and lesion. Topographical and morphological features play an important role in modulating cell behavior. In this study, a dual methodology was evaluated to generate novel gelatin methacrylate (GelMA)-based scaffolds with nano and micro topographical and morphological features. First, electrospinning parameters and crosslinking processes were optimized to obtain electrospun nanofibrous scaffolds. GelMA mats were characterized by SEM, FTIR, DSC, TGA, contact angle, and water uptake. Various nanofibrous GelMA mats with defect-free fibers and stability in aqueous media were obtained. Then, micropatterned molds produced by photolithography were used as collectors in the electrospinning process. Thus, biocompatible GelMA nanofibrous scaffolds with micro-patterns that mimic extracellular matrix were obtained successfully by combining two micro/nanofabrication techniques, electrospinning, and micromolding. Taking into account the cell viability results, the methodology used in this study could be considered a valuable tool to develop patterned GelMA based nanofibrous scaffolds for cell culture and tissue engineering.

Effect of poly (l-lactic acid) scaffolds seeded with aligned diaphragmatic myoblasts overexpressing connexin-43 on infarct size and ventricular function in sheep with acute coronary occlusion.

Diaphragmatic myoblasts (DM) are stem cells of the diaphragm, a muscle displaying high resistance to stress and exhaustion. We hypothesized that DM modified to overexpress connexin-43 (cx43), seeded on aligned poly (l-lactic acid) (PLLA) sheets would decrease infarct size and improve ventricular function in sheep with acute myocardial infarction (AMI). Sheep with AMI received PLLA sheets without DM (PLLA group), sheets with DM (PLLA-DM group), sheets with DM overexpressing cx43 (PLLA-DMcx43) or no treatment (control group, n = 6 per group). Infarct size (cardiac magnetic resonance) decreased ∼25% in PLLA-DMcx43 [from 8.2 ± 0.6 ml (day 2) to 6.5 ± 0.7 ml (day 45), p < .01, ANOVA-Bonferroni] but not in the other groups. Ejection fraction (EF%) (echocardiography) at 3 days post-AMI fell significantly in all groups. At 45 days, PLLA-DM y PLLA-DMcx43 recovered their EF% to pre-AMI values (PLLA-DM: 61.1 ± 0.5% vs. 58.9 ± 3.3%, p = NS; PLLA-DMcx43: 64.6 ± 2.9% vs. 56.9 ± 2.4%, p = NS), but not in control (56.8 ± 2.0% vs. 43.8 ± 1.1%, p < .01) and PLLA (65.7 ± 2.1% vs. 56.6 ± 4.8%, p < .01). Capillary density was higher (p < .05) in PLLA-DMcx43 group than in the remaining groups. In conclusion, PLLA-DMcx43 reduces infarct size in sheep with AMI. PLLA-DMcx43 and PLLA-DM improve ventricular function similarly. Given its safety and feasibility, this novel approach may prove beneficial in the clinic.

Aligned ovine diaphragmatic myoblasts overexpressing human connexin-43 seeded on poly (L-lactic acid) scaffolds for potential use in cardiac regeneration.

Diaphragmatic myoblasts (DMs) are precursors of type-1 muscle cells displaying high exhaustion threshold on account that they contract and relax 20 times/min over a lifespan, making them potentially useful in cardiac regeneration strategies. Besides, it has been shown that biomaterials for stem cell delivery improve cell retention and viability in the target organ. In the present study, we aimed at developing a novel approach based on the use of poly (L-lactic acid) (PLLA) scaffolds seeded with DMs overexpressing connexin-43 (cx43), a gap junction protein that promotes inter-cell connectivity. DMs isolated from ovine diaphragm biopsies were characterized by immunohistochemistry and ability to differentiate into myotubes (MTs) and transduced with a lentiviral vector encoding cx43. After confirming cx43 expression (RT-qPCR and Western blot) and its effect on inter-cell connectivity (fluorescence recovery after photobleaching), DMs were grown on fiber-aligned or random PLLA scaffolds. DMs were successfully isolated and characterized. Cx43 mRNA and protein were overexpressed and favored inter-cell connectivity. Alignment of the scaffold fibers not only aligned but also elongated the cells, increasing the contact surface between them. This novel approach is feasible and combines the advantages of bioresorbable scaffolds as delivery method and a cell type that on account of its features may be suitable for cardiac regeneration. Future studies on animal models of myocardial infarction are needed to establish its usefulness on scar reduction and cardiac function.

Recubrimiento de microesferas de quitosana-ibuprofeno con un complejo interpolimérico pH dependiente / Coating of chitosan-Ibuprofen microspheres with a pH-depending interpolymer complex

Introducción: el efecto irritante sobre la mucosa gástrica que producen los antiinflamatorios no esteroideos es una de sus principales reacciones adversas. La encapsulación de estos en matrices poliméricas con propiedades entéricas constituye una alternativa tecnológica para solucionar dicho problema. Objetivo: obtener micropartículas de quitosana cargadas con ibuprofeno recubiertas con un complejo interpolimérico pH dependiente a base de poli(ácido acrílico)/poli(N-vinil-2-pirrolidona). Métodos: se prepararon micropartículas de quitosana cargadas con ibuprofeno mediante secado por aspersión y se determinó el rendimiento del proceso y la eficiencia de encapsulación. Las micropartículas se recubrieron con un complejo interpolimérico pH dependiente de poli(ácido acrílico)/poli(N-vinil-2-pirrolidona), empleando la técnica de emulsión/evaporación del disolvente. Mediante espectroscopia infrarroja de transformada de Fourier, se comprobó la formación del complejo, y la evaluación morfológica se realizó por microscopia electrónica de barrido. Los estudios de liberación se realizaron en fluido gástrico e intestinal simulados (FGS pH= 1,2; FIS pH= 6,8). Resultados: en el proceso de obtención de las micropartículas de quitosana y quitosana-ibuprofeno hubo un rendimiento de 69 ± 1 por ciento y 54,4 ± 0,8 por ciento respectivamente. La eficiencia de encapsulación resultó de 46,8 ± 0,7 por ciento. Las micropartículas recubiertas presentaron una superficie rugosa. La formación del complejo se confirmó a través de los cambios observados en la posición de las bandas de absorción de los grupos funcionales involucrados en la formación del enlace por puente de hidrógeno. La liberación de ibuprofeno en FGS resultó del 40 por ciento para las micropartículas sin recubrimiento, mientras que fue despreciable en el caso de las micropartículas recubiertas durante el intervalo de tiempo estudiado. Conclusiones: los resultados muestran las potencialidades del complejo interpolimérico...

Introduction: the irritating effect on the gastric mucosa caused by non-steroidal anti-inflammatory drugs is one of the main adverse reactions. Their encapsulation in polymer matrices with enteric properties is a technological alternative to solve the problem. Objective: to obtain ibuprofen-loaded chitosan microparticles coated with a pH dependent interpolymer complex based on poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone). Methods: Ibuprofen-loaded chitosan microparticles were prepared through the spray drying technique; the yield and the efficiency of encapsulation were evaluated. Microparticles were coated with a pH-dependent interpolymer complex based on poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone) using the emulsion/solvent evaporation technique. The complex formation was verified by Fourier transform infrared spectroscopy and the morphological evaluation was made with the electronic scanning microscopy. Release studies used simulated gastric (SGF, pH= 1.2) and intestinal (SIF, pH= 6.8) fluids. Results: in the process of obtaining the chitosan and chitosan-ibuprofen microparticles, the yield rates amounted to 69 ± 1 percent and 54.4 ± 0.8 percent respectively were obtained. The encapsulation efficiency was 46.8 ± 0.7 percent. The coated microparticles presented rough surface. Complex formation was confirmed by changes in the position of the absorption bands of the functional groups involved in hydrogen bonding. The release of ibuprofen from uncoated microparticles in simulated gastrointestinal fluid reached 40 percent whereas it was neglectable in the coated microparticles during the study interval. Conclusions: the results show the potential of poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone) interpolymer complex as pH dependent cover for use as enteric coating to reduce the side effects on the gastric mucosa of medications such as non-steroidal anti-inflammatory drugs(AU)

Recubrimiento de microesferas de quitosana-ibuprofeno con un complejo interpolimérico pH dependiente / Coating of chitosan-Ibuprofen microspheres with a pH-depending interpolymer complex

INTRODUCCIÓN: el efecto irritante sobre la mucosa gástrica que producen los antiinflamatorios no esteroideos es una de sus principales reacciones adversas. La encapsulación de estos en matrices poliméricas con propiedades entéricas constituye una alternativa tecnológica para solucionar dicho problema. OBJETIVO: obtener micropartículas de quitosana cargadas con ibuprofeno recubiertas con un complejo interpolimérico pH dependiente a base de poli(ácido acrílico)/poli(N-vinil-2-pirrolidona) MÉTODOS: se prepararon micropartículas de quitosana cargadas con ibuprofeno mediante secado por aspersión y se determinó el rendimiento del proceso y la eficiencia de encapsulación. Las micropartículas se recubrieron con un complejo interpolimérico pH dependiente de poli(ácido acrílico)/poli(N-vinil-2-pirrolidona), empleando la técnica de emulsión/evaporación del disolvente. Mediante espectroscopia infrarroja de transformada de Fourier, se comprobó la formación del complejo, y la evaluación morfológica se realizó por microscopia electrónica de barrido. Los estudios de liberación se realizaron en fluido gástrico e intestinal simulados (FGS pH= 1,2; FIS pH= 6,8). RESULTADOS: en el proceso de obtención de las micropartículas de quitosana y quitosana-ibuprofeno hubo un rendimiento de 69 ± 1 por ciento y 54,4 ± 0,8 por ciento respectivamente. La eficiencia de encapsulación resultó de 46,8 ± 0,7 por ciento. Las micropartículas recubiertas presentaron una superficie rugosa. La formación del complejo se confirmó a través de los cambios observados en la posición de las bandas de absorción de los grupos funcionales involucrados en la formación del enlace por puente de hidrógeno. La liberación de ibuprofeno en FGS resultó del 40 por ciento para las micropartículas sin recubrimiento, mientras que fue despreciable en el caso de las micropartículas recubiertas durante el intervalo de tiempo estudiado. CONCLUSIONES: los resultados muestran las potencialidades del complejo interpolimérico poli(ácido acrílico)/poli(N-vinil-2-pirrolidona) como cubierta pH dependiente, con vistas a obtener un recubrimiento de tipo entérico que reduzca los efectos adversos sobre la mucosa gástrica de fármacos como los antiinflamatorios no esteroideos(AU)

INTRODUCTION: the irritating effect on the gastric mucosa caused by non-steroidal anti-inflammatory drugs is one of the main adverse reactions. Their encapsulation in polymer matrices with enteric properties is a technological alternative to solve the problem. OBJECTIVE: to obtain ibuprofen-loaded chitosan microparticles coated with a pH dependent interpolymer complex based on poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone). METHODS: Ibuprofen-loaded chitosan microparticles were prepared through the spray drying technique; the yield and the efficiency of encapsulation were evaluated. Microparticles were coated with a pH-dependent interpolymer complex based on poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone) using the emulsion/solvent evaporation technique. The complex formation was verified by Fourier transform infrared spectroscopy and the morphological evaluation was made with the electronic scanning microscopy. Release studies used simulated gastric (SGF, pH= 1.2) and intestinal (SIF, pH= 6.8) fluids. RESULTS: in the process of obtaining the chitosan and chitosan-ibuprofen microparticles, the yield rates amounted to 69 ± 1 percent and 54.4 ± 0.8 percent respectively were obtained. The encapsulation efficiency was 46.8 ± 0.7 percent he coated microparticles presented rough surface. Complex formation was confirmed by changes in the position of the absorption bands of the functional groups involved in hydrogen bonding. The release of ibuprofen from uncoated microparticles in simulated gastrointestinal fluid reached 40 percent whereas it was neglectable in the coated microparticles during the study interval. CONCLUSIONS: the results show the potential of poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone) interpolymer complex as pH dependent cover for use as enteric coating to reduce the side effects on the gastric mucosa of medications such as non-steroidal anti-inflammatory drugs(AU).

Physicochemical and antimicrobial properties of boron-complexed polyglycerol-chitosan dendrimers.

A polyglycerol with dendritic structure (PGLD) was synthesized by ring-opening polymerization of deprotonated glycidol using a polyglycerol as core functionality in a step-growth process. Then, PGLD reacted with O-carboxymethylated chitosan to obtain PGLD-chitosan dendrimer (PGLD-Ch). After the reaction of PGLD-Ch with boric acid, there was a marked increase in the bulk viscosity evidencing physically that boron can initiate a charge transfer complex formation, (PGLD-Ch)B. Gel permeation chromatography analysis was used to characterize the molecular weight and the polydispersivity of the synthesized PGLD-Ch. A dendritic structure with a molecular mass of 16.7 kDa and a narrow polydispersity (Mw/Mn = 1.05) was obtained. 1H-NMR and 13C-NMR measurements were employed to assess the degree of branching in PGLD. The obtained value of 0.85 indicates the tendency toward a dentritic structure for PGLD. The glass transition temperature values of (PGLD-Ch)B membranes containing 10% and 30% PGLD were -19 degrees C and -26 degrees C, respectively, which favor its potential use as surface coating of several polymers. The in vitro cytotoxicity was evaluated using the minimum essential medium elution test assay. Extracts of boron-complexed PGLD exhibited lower cytotoxicity than the controls, suggesting that the material has an improved biocompatibility. Antibacterial studies of (PGLD-Ch)B against Staphylococcus aureus and Pseudomonas aeruginosa showed a significant activity. Our study confirms and supports the effectiveness of (PGLD-Ch)B as an antimicrobial coating due to its capacity in suppressing the bacterial proliferation. The best in vivo response was found for (PGLD-Ch)B-30 membranes, which exhibited higher synthesis of collagen fibers than PGLD-ChB-10.

Macroporous poly(epsilon-caprolactone) with antimicrobial activity obtained by iodine polymerization.

The most serious problem usually encountered in the field of implanted biomedical devices is infectious morbidity as a primary source of mortality. In this work, the synthesis and characterization of a macroporous iodine-based sanitizer (iodophor), poly(caprolactone)-iodine (PCL-I(2)), are presented. Characterization methods include nuclear magnetic resonance spectroscopy, gel permeation chromatography, nitrogen adsorption-desorption, and scanning electron microscopy. The in vitro cytotoxicity to CHO cells based on cell viability with Chinese hamster ovary cells (CHO) and antimicrobial activities against Escherichia coli and Staphylococcus aureus were examined. The obtained macropore PCL-I(2) structures had a rather narrow size distribution. The PCL-I(2) iodophor was noncytotoxic to Chinese hamster ovary cells. The antimicrobial activities of the PCL-I(2) were assessed against E. coli and S. aureus. The tested PCL-I(2) showed better antimicrobial activity against E. coli than against S. aureus.

Development of new hydroactive dressings based on chitosan membranes: characterization and in vivo behavior.

Different poly(vinyl alcohol) (PVA)/chitosan lactate (ChL)-blended hydrogels containing nitrofurazone as a local anti-infective drug were prepared by the phase-inversion technique. The swelling degree, surface free energy, mechanical properties, and nitrofurazone release of these membranes were determined. Blood compatibility of these systems was evaluated by the open-static platelet adhesion test with whole human blood. The results showed that water absorption into the PVA/ChL membranes slowed down, governed by the rate at which the dressing interacted with the physiological fluid. Swelling degree values up to 200% were observed. The rate of release of nitrofurazone seemed to depend on the ChL percentage on the blend as well as the pH of the solution. The surface free energy values were in the range of 20-30 dynes/cm, which was appropriate for a favorable interaction with blood. From the Young's module curve, it could be seen that elastic hydrogels were obtained with increment of ChL in the PVA/ChL blends. Values of platelet adhesion and whole blood clotting times for the PVA/ChL blends as well as the increase of ChL, which appears to reduce the fibrinogen adsorption on the PVA/ChL membranes, demonstrated that the blood compatibility of PVP/ChL blends is superior to that separated polymers. The results of in vivo experiments in rats were in very good agreement with these observations, suggesting that PVA/ChL may serve as a new type of potential wound-dressing material.